NCC BOARDS CLINICAL PEARLS Flashcards
45 M with possible seizure history presents after seizure activity resulting in a ground level fall. In the ED he has a witnessed seizure. CT head demonstrates temporal SAH. He has an anaphylactic reaction to contrast and a skull fracture overlying the dural sinus. Imaging is required to rule out a dural sinus thrombosis. He requires intubation to allow for adequate sedation for MRV to evaluate the sinus. On hospital day 3 he develops hypoxia and new thick secretions with fevers. Which broad spectrum antibiotic should be started given his history of seizures and current epileptiform activity on continuous EEG?
Zosyn
- Cefepime lowers seizure threshold
When do you use different forms of valproic acid?
Difference between different anti epileptic meds
Which ICH/SAH/SDH locations increase seizures or predispose a patient to seizures?
Which medications lower seizure threshold?
Which seizure drugs affect anticoagulation? Or which anticoagulation drugs affect seizure medications?
Which antiepileptic meds require renal dosing?
Interactions between antipsychotics and seizure medications/thresholds?
Stepwise management of seizures inpatient and outpatient?
What is the Fisher Grading Scale of SAH?
Main difference between SIADH and Cerebral Salt Wasting?
Check intravascular volume -
- CSWS - hypovolemia (water problem)
- SIADH - euvolemia (salt problem)
- Both have Na <135, Serum Osm < 285, urine Na >25, urine osm >200
Medications associated with SIADH?
TBI, brain tumor, CVA, brain infection, SAH, ICH, pneumonia/TB, lung cancer, meds, SSRI, TCA, cabamazepine, oxcarbazepine, chlorpropamide, nicotine, opioids, antipsychotics, NSAIDS
- SCANT COON - SSRI, chlorpropamide, antipsychotics, NSIADS, TCAs, carbemapezine, oxcrbazepine, opioids, nicotine
Treatment strategies for SIADH?
Fluid restriction of free water, supplement Na (PO «_space;IV - NS vs 3%), demeclocycline (takes >1 wk), vasopressin antagonists (prompt response over first 24 hours, causes diuresis)
What were the SALT 1 and 2 trials?
SALT-1 patients with tolvaptan had change in serum sodium to day 4 of 3.6 versus 0.25 in placebo. SALT-2 was 4.33 vs 0.42
Two multicenter randomized double blind placebo-controlled trials in patients with hyponatremia from CHF, cirrhosis and SIADH (SALT-1 US and SALT-2 international) - PO placebo versus tolvaptan (vasopressin antagonist) - serum sodium returned to placebo level when stopped
What is cerebral salt wasting? How is it treated?
Etiology unknown but typically caused by increased secretion of natriuretic peptides causing loss of Na at the renal distal tubules
Tx: Na containing fluid (NS versus 3%)
Fludrocortisone 0.1-0.4 mg/day may be helpful in reducing Na loss in CSWS